… paper, we review the pharmacology of direct oral anticoagulants, … perspectives for the
development of oral anticoagulants. … thromboembolism: a systematic review and meta-analysis. …

… The anticoagulant effects of oral anticoagulants not only vary markedly among individuals
but … This systematic review was performed to document the incidence of oral anticoagulant-…

… Although their first application in clinical practice occurred in the 1940s, vitamin K
antagonists remain the only form of oral anticoagulant medication approved for long-term use. …

… We systematically reviewed and meta-analysed clinical outcomes with direct oral anticoagulants
(DOAC: dabigatran, rivaroxaban, apixaban or edoxaban) for treatment of acute VTE. …

… We performed a systematic review of the literature to examine use of coagulation assays
for assessment of the anticoagulant activity of DOACs. A search of PubMed, Web of Science, …

… -weight heparin (LMWH) while oral anticoagulation is withheld can decrease the risk of …
To better inform clinicians on the available evidence, we performed a systematic review and …

… of a third reviewer (WA) if necessary. Studies were considered potentially eligible for this
systematic review if they met … Twelve studies were therefore included in this systematic review. …

… Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists
in the treatment of acute symptomatic venous thromboembolism: a systematic review and …

… For more than 50 years, vitamin K antagonists (eg, warfarin) were the only available oral
anticoagulants. It has now been 3 years since the first of the new oral anticoagulants (NOACs), …

… Despite an efficacious oral anticoagulation therapy (warfarin), atrial fibrillation patients at
high risk for stroke are often under-treated. This systematic review compares current treatment …